Xiaoxiao Huang

Xiaoxiao Huang

Regeneron Pharmaceuticals Inc - Warsaw / United States
Natural Sciences / Molecular Biology & Genetics
AD Scientific Index ID: 4459373
-
person_outline Xiaoxiao Huang's MOST POPULAR ARTICLES
1-) Point mutation E1099K in MMSET/NSD2 enhances its methyltranferase activity and leads to altered global chromatin methylation in lymphoid malignanciesJA Oyer, X Huang, Y Zheng, J Shim, T Ezponda, Z Carpenter, M Allegretta, ...Leukemia 28 (1), 198-201, 20141362014
2-) UTX/KDM6A loss enhances the malignant phenotype of multiple myeloma and sensitizes cells to EZH2 inhibitionT Ezponda, D Dupéré-Richer, CM Will, EC Small, N Varghese, T Patel, ...Cell reports 21 (3), 628-640, 20171332017
3-) A mutation in histone H2B represents a new class of oncogenic driverRL Bennett, A Bele, EC Small, CM Will, B Nabet, JA Oyer, X Huang, ...Cancer discovery 9 (10), 1438-1451, 2019732019
4-) Epiproteomics: quantitative analysis of histone marks and codes by mass spectrometryY Zheng, X Huang, NL KelleherCurrent opinion in chemical biology 33, 142-150, 2016782016
5-) An activating mutation of the NSD2 histone methyltransferase drives oncogenic reprogramming in acute lymphocytic leukemiaA Swaroop, JA Oyer, CM Will, X Huang, W Yu, C Troche, M Bulic, ...Oncogene 38 (5), 671-686, 2019552019